Divis Laboratories, a pharmaceutical ingredients and intermediates company, posted a consolidated rise of 17.84% to Rs 2.31 billion in the quarter ended March 2015 as against Rs 1.96 billion during the previous quarter ended March 2014.

Total income rose 9.56% to Rs 8.32 billion in the quarter ended March 2015 as against Rs 7.59 billion during the previous quarter last year.

Shares of the company declined Rs 32.7, or 1.77%, to trade at  Rs 1,813.75.  The total volume of shares traded  was  21,148 at the BSE (1.29 p.m., Monday).